- Conditions
- Fructan Intolerance
- Interventions
- Sacrosidase Oral Solution, Placebo
- Drug
- Lead sponsor
- QOL Medical, LLC
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–2
of 2
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Congenital Sucrase-Isomaltase Deficiency, CSID, Sucrase Isomaltase Deficiency
- Interventions
- Sucraid (sacrosidase) Oral Solution 8500 IU/mL
- Biological
- Lead sponsor
- QOL Medical, LLC
- Industry
- Eligibility
- 6 Months to 17 Years
- Enrollment
- 312 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 20
- States / cities
- Los Angeles, California • Oakland, California • Coral Gables, Florida + 13 more